Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Batus, M. [1 ]
Mohajer, R. [1 ]
Pach, D. [1 ]
Basu, S. [1 ]
Fidler, M. J. [1 ]
Bonomi, P. D. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18047
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE II TRIAL OF PACLITAXEL POLIGLUMEX(CT-2103) IN PRE- AND POST-MENOPAUSAL WOMEN ON HORMONAL REPLACEMENT THERAPY (HRT) WITH NON SMALL CELL LUNG CANCER (NSCLC)
    Mohajer, Roozbeh
    Batus, Marta
    Pach, Debra
    Basu, Sanjib
    Fidler, Mary J.
    Bonomi, Philip
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1252 - S1252
  • [2] Paclitaxel poliglumex (PPx, CT-2103): macromolecular medicine for advanced non-small-cell lung cancer
    Bonomi, Philip
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (04) : 415 - 422
  • [3] Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer
    Langer, Corey J.
    O'Byrne, Kenneth J.
    Socinski, Mark A.
    Mikhailov, Sergei M.
    Lesniewski-Kmak, Krzysztof
    Smakal, Martin
    Ciuleanu, Tudor E.
    Orlov, Sergey V.
    Dediu, Mircea
    Heigener, David
    Eisenfeld, Amy J.
    Sandalic, Larissa
    Oldham, Fred B.
    Singer, Jack W.
    Ross, Helen J.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : 623 - 630
  • [4] A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC).
    Lynch, TJ
    Lilenbaum, R
    Bonomi, P
    Ansari, R
    Govindan, R
    Janne, PA
    Hanna, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 637S - 637S
  • [5] A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC)
    Hanna, N
    Bonomi, P
    Lynch, T
    Ansari, R
    Govindan, R
    Janne, R
    Lilenbaum, R
    LUNG CANCER, 2005, 49 : S38 - S38
  • [6] Symptom relief in patients with non-small cell lung cancer (NSCLC) after treatment with paclitaxel poliglumex (PPX, XYOTAXTM):: phase III trial results
    Thatcher, N.
    EJC SUPPLEMENTS, 2005, 3 (02): : 325 - 325
  • [7] Phase II study of oxaliplatin and paclitaxel in advanced non-small cell lung cancer (NSCLC).
    Mauer, AM
    Otterson, G
    Rudin, CM
    Villalona, M
    Ansari, RH
    Szeto, L
    Vokes, EE
    CLINICAL CANCER RESEARCH, 2000, 6 : 4576S - 4576S
  • [8] Phase II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Lazaro, M
    Jorge, M
    Castellanos, J
    ANNALS OF ONCOLOGY, 2000, 11 : 109 - 109
  • [9] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [10] Randomized phase III trial comparing single-agent paclitaxel poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer
    O'Brien, Mary E. R.
    Socinski, Mark A.
    Popovich, Alexander Y.
    Bondarenko, Igor N.
    Tomova, Antoaneta
    Bilynskyi, Borys T.
    Hotko, Yevhen S.
    Ganul, Valentin L.
    Kostinsky, Ippolit Y.
    Eisenfeld, Amy J.
    Sandalic, Larissa
    Oldham, Fred B.
    Bandstra, Bruce
    Sandler, Alan B.
    Singer, Jack W.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (07) : 728 - 734
12345